Kimberly-Clark to acquire Tylenol maker Kenvue in US$48.7bn deal
Kimberly-Clark is set to acquire Kenvue in a cash and stock transaction valuing Kenvue at about US$48.7 billion (A$74 billion).
Kimberly-Clark to acquire Tylenol maker Kenvue in US$48.7bn deal Read More »